Obbligazioni TEVA
Di seguito è riportato l'elenco delle obbligazioni societarie Teva Pharmaceutical Industries Limited. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 8,41% | 500 K | 99,73% | 7,13% | 2025-01-31 | 425,26 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 7,60% | 0 | 71,25% | 4,10% | 2046-10-01 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6,96% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 6,44% | 0 | 101,25% | 7,13% | 2025-01-31 | 1,25 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6,17% | 0 | 99,89% | 6,15% | 2036-02-01 | 789,43 M USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTFABTEVA P.FI.NL III 16/26 | 5,94% | 0 | 95,33% | 3,15% | 2026-10-01 | 3,38 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5,89% | 4,68 M | 97,30% | 5,13% | 2029-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5,85% | 2 M | 97,63% | 4,75% | 2027-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,78% | 1,28 M | 102,66% | 6,75% | 2028-03-01 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,77% | 1 M | 107,95% | 7,88% | 2029-09-15 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,75% | 1,97 M | 111,61% | 8,13% | 2031-09-15 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5,16% | 0 | 100,17% | 6,00% | 2025-01-31 | 410,61 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4,50% | 0 | 100,00% | 4,50% | 2025-03-01 | 494,35 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4,20% | 0 | 100,80% | 4,38% | 2030-05-09 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4,17% | 0 | 119,64% | 7,88% | 2031-09-15 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4,05% | 0 | 113,41% | 7,38% | 2029-09-15 | 800 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3,98% | 0 | 95,46% | 1,88% | 2027-03-31 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3,92% | 0 | 99,61% | 3,75% | 2027-05-09 | 1,1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3,91% | 0 | 92,26% | 1,63% | 2028-10-15 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2,57% | 0 | 98,95% | 1,00% | 2025-07-28 | 350 M CHF | 5.000,00 CHF | 5.000,00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2,17% | 430 K | 97,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1.000,00 USD | 1.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | — | 1,88% | 2024-12-15 | 333 M USD | 1.000,00 USD | 1.000,00 USD | IVAX LLC |